Esomelodan is a proton pump inhibitor formulated as enteric‑coated tablets to ensure targeted release in the intestine. It effectively reduces gastric acid secretion and is indicated for managing a variety of acid-related gastrointestinal conditions.

Benefits:
- Reduces symptoms of gastroesophageal reflux disease, such as heartburn and acid regurgitation.
- Prevents stomach ulcers, especially in patients taking NSAIDs.
- Aids in healing erosive esophagitis caused by acid damage.
- Used as part of a combination therapy to eradicate Helicobacter pylori infections.

Main Ingredient and Its Benefits:
- Esomeprazole: This is the primary active ingredient in Esomelodan, a proton pump inhibitor (PPI) that reduces stomach acid production, providing relief from gastroesophageal reflux disease (GERD), peptic ulcers, and other related conditions by promoting healing of the esophagus and alleviating symptoms such as heartburn.